Next Article in Journal
Effect of Heat Treatment on the Quality and Soft Rot Resistance of Sweet Potato during Long-Term Storage
Previous Article in Journal
Development of an Innovative Optoelectronic Nose for Detecting Adulteration in Quince Seed Oil
Previous Article in Special Issue
Antioxidant Effects of Turbo cornutus By-Products Visceral Extract against Hydrogen Peroxide-Induced Oxidative Stress by Regulating MAPK and Akt Signaling Pathways in Vero Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Foods
Volume 12
Issue 23
10.3390/foods12234351
foods-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Grapevine Shoot Extract Rich in Trans-Resveratrol and Trans-ε-Viniferin: Evaluation of Their Potential Use for Cardiac Health

by
María del Mar Contreras
1,2,*,
Anouar Feriani
3,
Irene Gómez-Cruz
1,2,
Najla Hfaiedh
3,
Abdel Halim Harrath
4,
Inmaculada Romero
1,2,
Eulogio Castro
1,2 and
Nizar Tlili
5
1
Department of Chemical, Environmental and Materials Engineering, Campus Las Lagunillas, Universidad de Jaén, 23071 Jaén, Spain
2
Centre for Advanced Studies in Earth Sciences, Energy and Environment (CEACTEMA), Campus Las Lagunillas, Universidad de Jaén, 23071 Jaén, Spain
3
Laboratory of Biotechnology and Biomonitoring of the Environment and Oasis Ecosystems, Faculty of Sciences of Gafsa, University of Gafsa, Gafsa 2112, Tunisia
4
Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
5
Institut Supérieur des Sciences et Technologies de l’Environnement, Université de Carthage, Hammam Chat 2050, Tunis 1073, Tunisia
*
Author to whom correspondence should be addressed.
Foods 2023, 12(23), 4351; https://doi.org/10.3390/foods12234351
Submission received: 30 October 2023 / Revised: 24 November 2023 / Accepted: 27 November 2023 / Published: 2 December 2023
(This article belongs to the Special Issue Research Advances of Food By-Products and Derived Extracts: Novel Foods or Food Additives?)
Browse Figures
Versions Notes

Abstract

:
A grapevine shoot extract (GSE) was obtained using ultrasound-assisted extraction and characterized. The main phenolic constituents were identified as stilbenoids. Among them, trans-resveratrol and trans-ε-viniferin stood out. The GSE was administered to an isoproterenol-induced myocardial injury animal model. The extract alleviated the associated symptoms of the administration of the drug, i.e., the plasma lipid profile was improved, while the disturbed plasma ion concentration, the cardiac dysfunction markers, the DNA laddering, and the necrosis of myocardial tissue were diminished. This effect could be related to the anti-oxidative potential of GSE associated with its antioxidant properties, the increased levels of endogenous antioxidants (glutathione and enzymatic antioxidants), and the diminished lipid peroxidative markers in the heart. The results also revealed angiotensin-converting enzyme (ACE)-inhibitory activity, which indicated the potential of GSE to deal with cardiovascular disease events. This work suggests that not only trans-resveratrol has a protective role in heart function but also GSE containing this biomolecule and derivatives. Therefore, GSE has the potential to be utilized in the creation of innovative functional ingredients.

Graphical Abstract

1. Introduction

In 2022, the world vineyard surface was about 7.3 million hectares, a value that seems to have remained stable since 2017. It was dedicated to vines for wine, juice, table grapes, and dried grapes [1]. For vineyard management, pruning is aimed to ensure optimal grape production and quality [2]. In this practice, grapevine shoots are generated as waste, whose current management (habitual burning in the field) generates environmental impact [3]. By incorporating grapevine shoots into a circular bioeconomy framework, vineyards and related industries can contribute to resource efficiency, waste reduction, and sustainable practices that benefit both the environment and the economy.
A potential means of valorization could be the extraction of bioactive compounds, including stilbenoids, which are health-promoting compounds. They can find food applications (e.g., as preservatives and functional ingredients), medical applications, and uses as vine biostimulants [4]. Among the stilbenoids, resveratrol stands out, but it presents a high variation in this type of biomass; in some samples, this compound was not detected [5], while in others its concentration can reach about 7 g per kg of biomass [6]. Some factors affecting this variation are the genotype (or the cultivar type), climate, agronomic practices, and stress-related factors [6]. Particularly, grapevine shoots of traditional and non-traditional cultivars have been evaluated, for example, from Spain [5,7], Portugal [8], Italy [9], and France [10]. Other cultivars, like the Spanish white grape cultivar ‘Charelo’ (or Xarel·lo), have been poorly studied.
The extraction conditions can also affect the phenolic profile and yield [3,8] and hence they should be jointly evaluated with other factors such as the cultivar. For this purpose, several works described the application of green technologies to provide efficient extraction, e.g., high-voltage electrical discharge [11], microwave [5,12], subcritical water [12], and ultrasound [5]. The latter technology has shown good extraction performance both in the laboratory and at the pilot scale, highlighting its suitability for industrial application [8].
In this context, the main aim of the work was to characterize and evaluate the bioactive potential of a grapevine shoot extract (GSE) obtained from the cultivar ‘Charelo’ using ultrasound-assisted extraction (UAE). First, the phenolic composition was further characterized. Other compounds (sugars, alditols, and organic acids) were also quantified to provide more information about the overall composition of the extract. Second, the efficacy of the GSE on an isoproterenol (ISP)-induced heart injury model was studied. Although there is evidence of the protective role of trans-resveratrol on cardiovascular and heart health [13], this work brings new insights into the potential use of natural extracts containing trans-resveratrol and trans-ε-viniferin to provide functional ingredients for the food, pharma, and nutraceutical sectors.

2. Materials and Methods

2.1. Raw Biomass and Extraction

Grapevine shoots were obtained from a local company in the Penedés region (northeast of Spain) and air-dried to about 8% humidity. The sample was milled to ~1 mm with an ultracentrifugal ZM 200 mill (Retsch GmbH, Haan, Germany). Then, the sample was extracted under previously optimized conditions using 10% solids (w/v) suspended in 80% ethanol aqueous solution and ultrasonicated for five min at 80% amplitude with a Sonifier SF550 (Branson, L’Hospitalet de Llobregat, Spain). The extraction was initiated at room temperature (~20 °C) and monitored at the end of the experiments (57 °C). The extract was finally freeze-dried (Noxair freeze-drier, Barcelona, Spain). This extract (GSE) was further characterized and administered to the animal model.
Moreover, maceration for 24 h was applied as control using the same solid-to-liquid ratio (10%, w/v) and solvent (80% ethanol) at room temperature and aided by agitation at 150 rpm in an incubation shaker (InforsHT Ecotron, Surrey, UK).

2.2. Characterization of the Extract

2.2.1. Phenolic Content, Composition, and Antioxidant Assays

GSE was redissolved in 80% (v/v) ethanol for analysis. The total phenolic content (TPC) was measured by a colorimetry test using Folin and Ciocalteu’s phenol reagent in microplates from Sigma-Aldrich (St. Louis, MO, USA) in a Bio-RadiMark™ device (Hercules, CA, USA), according to a previous study [14]. The antioxidant activity was determined using the ferric reducing power (FRAP) at 734 nm in the aforementioned device [14]. Commercial gallic acid (TPC) and Trolox (FRAP), both from Sigma-Aldrich, were used for comparison [14].
The phenolic profiles were acquired using two methodologies, one using high-performance liquid chromatography (HPLC) and UV detection and the other based on HPLC–quadrupole time-of-flight (QTOF)–mass spectrometry (MS), according to a previous study [15]. The former analysis was performed in a Prominence UFLC chromatograph (Shimadzu Corporation, Kyoto, Japan) using a BDS HYPERSIL column (C18 with 5 μm particle size; dimensions, 4.6 mm × 250 mm) (Thermo Fisher Scientific Inc., Waltham, MA, USA). The gradient conditions and mobile phases were in accordance with previous studies [14,15]. The commercial standards of trans-resveratrol and trans-ε-viniferin were obtained from Extrasynthese (Genay, France) and used for quantification in the aforementioned chromatographic conditions at 280 nm. The curves were y = 55,984x + 347,526 (R2 = 0.992) for trans-resveratrol and y = 28,962x + 315,646 (R² = 0.998) for trans-ε-viniferin.
The RP-HPLC-QTOF-MS analysis was conducted in an Agilent 1200 HPLC connected online to an Agilent 6530B QTOF mass analyzer through an electrospray interface using the negative ionization mode (Agilent Technologies, Santa Clara, CA, USA). A C18 column (a core-shell Kinetex with 2.7 µm particle size; dimensions, 2.1 mm × 50 mm) (Phenomenex, Barcelona, Spain) was used by applying a gradient with 0.1% v/v formic acid and acetonitrile [15]. The mass formula was generated with a mass error lower than 5 ppm for characterization purposes using an Agilent MassHunter Qualitative Analysis B.06.00 (Agilent Technologies). The peak area of the ions was obtained to estimate the relative abundance.

2.2.2. Other Components

The carbon, hydrogen, nitrogen, and sulfur contents of the GSE were obtained via combustion of about 2 mg of sample in a TruSpec Micro device (LECO corporation; St. Joseph, MI, USA). The protein content was estimated as the nitrogen content × 6.25.
The lyophilized GSE was dissolved in ultrapure water for the subsequent analyses and analyzed following a previous study [14]. The sugar content was quantified using a Waters Prostar HPLC device with refractive index detection (RID) (Milford, MA, USA) [14]. Moreover, the content of organic acids was quantified with HPLC–RID in an Agilent HPLC 1260 series device (Agilent Technologies). The columns were CARBOSep CHO-782 Pb and ICSep ICE-COREGEL 87 H3 from Transgenomic, Inc. (Omaha, NE, USA) heated at 70 °C and 65 °C, respectively. The mobile phases were ultrapure water and ultrapure water with sulfuric acid (5 mM) flowing at 0.6 mL/min, respectively [14].

2.3. In Vivo Evaluation of the Cardiac Protective Activity

2.3.1. Animals

The current investigation was granted approval by the Ethical Committee for the Care and Use of Laboratory Animals (reference no. FSG-04-23; University of Gafsa, Tunisia). Forty-eight Wistar male rats, with a body weight (bw) of about 230–250 g, were purchased from SIPHAT (Ben Arous, Tunisia). They were kept housed with unrestricted access to water and food, and the light (12 h), temperature (22–24 °C), and humidity (50%) were controlled.

2.3.2. Acute Preliminary Toxicity Effect

GSE in saline was administered orally to the rats at 5, 10, 20, 40, and 60 mg GSE/kg bw doses, with six animals in each group. For comparison, the treated animals and untreated rats (n = 6) were carefully observed for any toxicological symptoms within 24 h and during a subsequent 21-day observation period.

2.3.3. Experimental In Vivo Assay

The rats were adapted for 15 days to the aforementioned conditions and then split into six groups (n = 6, per group). The duration of the experiment and treatments was 30 days as follows:
Groups I (C): Control rats that were not subjected to any treatment, received daily doses of saline solution (1 mL each dose).
Groups II (GSE1): rats were treated with 1 mL of saline solution containing GSE (20 mg GSE/kg bw) for 28 days. The administration was carried out by gavage.
Groups III (GSE2): rats were treated with 1 mL of saline solution containing GSE (40 mg GSE /kg bw) for 28 days. The administration was carried out by gavage.
Groups IV (ISP): ISP in saline was injected (85 mg/kg bw) for two successive days (on the 29th and 30th days). Saline solution was administered daily for 28 days before injection of ISP.
Groups V (GSE1 + ISP): 1 mL of saline solution containing GSE (20 mg GSE/kg bw) was administered daily by gavage for 28 days, and ISP in saline was then injected on the 29th and 30th days.
Groups VI (GSE2 + ISP): 1 mL of saline solution containing GSE (40 mg GSE/kg bw) was administered daily by gavage for 28 days, and ISP in saline was then injected on the 29th and 30th days.

2.3.4. Electrocardiogram

The electrocardiographic test was realized with an ECG VET 110 electrocardiograph (Biocare, Shenzhen, China) after isoproterenol was injected (30th day) and before the sacrifice. Rats received anesthesia using ketamine hydrochloride (100 mg/kg bw) intraperitoneally and needle electrodes were non-invasively inserted in the lead II position after 15 min.

2.3.5. Biological Sample Collection

Blood from rats was collected in ethylenediaminetetraacetic acid (EDTA) just after being sacrificed by cervical decapitation. The blood was subjected to 10 min centrifugation at 3500 rpm at 4 °C to recover the plasma. The hearts were collected, weighed, and washed. To determine the myocardial infarction (MI) area, some fragments of the hearts were fixed using 1% 2,3,5-triphenyltetrazolium chloride (TTC) in phosphate-buffered saline for 15 min. For histopathological analysis, other fragments of the hearts were fixed using 10% buffered formaldehyde. The remaining fragments were maintained at −70 °C for further studies.

2.3.6. Analysis of Cardiac Parameters in Plasma

Various commercial kits from Zellbio (Lonsee, Germany) were applied to determine the concentration of aspartate aminotransferase (AST), lactate dehydrogenase (LDH), fibrinogen, and creatine kinase-MB (CK-MB). Moreover, the cardiac troponin (cTn-I) amounts were estimated using a Roche Diagnostics immunoassay based on electrochemiluminescence (Basel, Switzerland). The activity of angiotensin-converting enzyme (ACE) was calculated using standard kits (Trinity Biotech’s, Bray, Ireland).
LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C), triglycerides (TG), and total cholesterol (TC) amounts were calculated according to the Biomaghreb kit’s manufacturer (Tunisia).
The concentration of electrolytes (Na+ and Ca2+) was determined using an EasyLyte Plus ionogramme analyzer (Medica; Bedford, MA, USA).

2.3.7. Determination of Cardiac Pro-Antioxidant and Antioxidants Levels

Oxidative stress was estimated in the heart tissue homogenate through the measurement of thiobarbituric acid reactive substances (TBARS) to express the nmol malonaldehyde (MDA)/g tissue following the reported methodology [16].
The endogenous antioxidant potential was estimated by measuring the level of activity of superoxide dismutase (SOD) and catalase (CAT) according to published protocols [17,18], respectively, and cellular glutathione (GSH) determination was performed according to a previous method [19], and according to Chtourou et al. [20]. The protein content was quantified following Bradford’s study [21].

2.3.8. DNA Fragmentation Analysis

DNA from the hearts of animals was extracted using the methodology previously reported [20]. The obtained DNA was stained using ethidium bromide and placed on agarose gel for electrophoresis (0.8%), which was observed and UV photographed for interpretation.

2.3.9. Determination of Heart Pro-Apoptotic Genes

The apoptosis event was inspected in the myocardial tissue using real-time (RT)-PCR assays of three genes (B-cell lymphoma-2 associated-x or Bax, B-cell lymphoma-2 or Bcl2, and caspase-3) following Chtourou and colleagues’ study [20]. Briefly, 2 µg of isolated mRNA was reversely transcribed using the Invitrogen superscript reverse transcriptase. The amplification was performed by applying previously described RT cycler conditions [22] and the primer sequences described in Table S1 for the RT-PCR. Ethidium bromide was used for staining the PCR products after electrophoresis on 1.8% agarose gel. Finally, the software ImageJ 1.54f (NIH, MD, USA) was used to determine the mRNA expressions of the genes.

2.3.10. Infarct Size Determination

The hearts were fixed in 1% TTC according to a previously reported method [23] (Section 2.3.5.). The color red indicated normal myocardial tissue, while a pale orange suggested damaged areas.

2.3.11. Histopathological Analysis

Hematoxylin-eosin (H&E) staining was used on 5 μm cut sections from paraffin blocks [23], which were then analyzed under light microscopy and photographed.

2.4. Statistical Analysis

Data from the characterization represent the mean or the mean ± standard deviation (SD) of three analyses. Data from in vivo experiments represent the mean ± SD (six rats/group) and they were analyzed via a one-way analysis of variance and Tukey’s test (p < 0.05 for statistical significance) with GraphPad Prism 4.02 (Boston, MA, USA).

3. Results

3.1. Phenolic Composition and Antioxidant Potency

The TPC and the antioxidant potential of the GSE, which was obtained by UAE, are shown in Table 1. The TPC was 207.3 g/g GSE, which is about 8 mg/g grapevine shoots (on a dry basis). The main phenolic compounds obtained by UAE from the grapevine shoots were trans-resveratrol and trans-ε-viniferin, as suggested by the HPLC-UV analysis at 280 nm (Figure 1). These compounds were quantified for the standardization of the GSE, highlighting that they contained about 27.4 ± 0.3 mg/g GSE and 29.2 ± 0.2 mg/g GSE, respectively.
The extract was also further characterized using QTOF-MS-based analysis. The compounds were tentatively characterized based on the retention time, generated molecular formula, and literature on phenolic compounds found in grapevine plant parts and wine-associated waste (particularly, [6]). The results are shown in Table 2, which depicts that 27 phenolic compounds were found globally. They were classified as stilbenoids, which were distributed as four monomers, nine dimers, two trimers, and five tetramers, simple phenolic compounds (a hydroxybenzoic acid, gallic acid, and two phenol aldehydes), three monomeric flavanols, and a B-type dimeric flavanol. Figure 1b illustrates the overall distribution of phenolic compounds based on the relative area measured analysis by RP-HPLC-QTOF-MS. This semi-quantitative analysis suggested that GSE was rich in stilbenoids in monomeric and dimeric forms (Figure 1c), with trans-resveratrol and its dimer trans-ε-viniferin prominent among them, as detected by UV.

3.2. Other Components of GSE

The elemental analysis, including the carbon, hydrogen, nitrogen, and sulfur contents of the GSE, is shown in Table 3, along with other components that could be characterized in the extract, i.e., carbohydrates in monomeric and oligomeric forms, alditols (mannitol), and organic acids (acetic and formic acids). These results suggest that overall, the extract contained about 9% moisture and consisted of about 20% TPC, 11% glucose carbohydrates, 0.3% galactose carbohydrates, 3% mannitol, 4% organic acids, 7% crude protein, and 6% inorganic components, determined as ash.

3.3. Preliminary Acute Toxicity Evaluation

Using the tested doses of GSE, no alterations in the behavior were noted, and the mortality of the animals remained unchanged up to 60 mg GSE/kg bw.

3.4. Effect of GSE on Rats’ Weight

The results relative to rats’ body and heart weight and CWI are presented in Table 4. The studied groups did not exhibit any substantial changes in body weight. Nevertheless, the highest CWI (p < 0.05) was observed in the ISP group. It was also remarkable that GSE1 or GSE2 pre-co-treatment induced a significant decrease in relative heart weight in comparison with the ISP group.

3.5. Effect of GSE on ST-Segment

In comparison with the normal group C, the results showed that the ISP group presented an elevated ST-segment (Pardee wave) which is related to MI (Figure S1). The pre-co-treatments with GSE1 or GSE2 reduced the ECG perturbation by the decrease in the ST-segment by comparison with the animals that solely received ISP. It was also remarkable that GSE2 was more effective than GSE1 against ISP administration.

3.6. Effect of GSE on the Cardiac Indicators of Injury

The activities of AST, CK-MB, LDH, and cTn-I associated with the cardiac injury of all groups are shown in Figure 2. The results showed that the activities of the targeted markers were higher in the ISP group than in the control rats. GSE1 or GSE2 pre-co-treatment remarkably attenuated the effect of ISP on the studied enzymes and decreased their activities, when compared to ISP-treated animals. No substantial variations in these markers were noted among the GSE1-ISP and the GSE2-ISP rats.

3.7. Effect of GSE on Fibrinogen Concentration

As Figure 3a shows, the concentration of plasmatic fibrinogen in the ISP-treated animals increased in comparison with the control group, at p < 0.0001. This figure also shows that the pre-co-administration of GSE diminished the fibrinogen concentration at p < 0.05 in contrast with the ISP group.

3.8. Effect of GSE on ACE

Figure 3b displays the activity of ACE in the studied animals. Rats treated with ISP presented a high activity of ACE in comparison with the control group (p < 0.0001). Alternatively, the association of ISP with GSE1 or GSE2 remarkably decreased (p < 0.05) the enzyme activity compared to the aforementioned group.

3.9. Effect of GSE on Plasmatic Lipids

The lipid profile was significantly disrupted by ISP as observed in the ISP group plasma (Table 5). It was clear that ISP increased the TC, TG, and LDL-C amounts, and decreased the HDL-C level at p < 0.05. The administration of ISP with GSE1 or GSE2 restored the concentration of lipid markers to normal levels (p < 0.05).

3.10. Effect of GSE on Major Plasma Electrolytes

Table 5 also depicts the impact of the studied interventions on the concentrations of electrolytes in plasma. In contrast to the control animals, the obtained data suggested that the administration of ISP notably enhanced (p < 0.05) the amounts of Ca2+ and diminished the concentration of Na+. However, rats subjected to the combined treatment with GSE1 or GSE2 showed levels of targeted electrolytes near normal values detected in control groups.

3.11. Effect of GSE on MDA, CAT, SOD, and GSH Levels

The levels of MDA together with the activity of SOD and CAT, as oxidative stress biomarkers in the cardiac tissue, are shown in Table 5. The results suggest that the administration of ISP elevated the amounts of MDA and jointly decreased the activities of the targeted enzymes, as well as the GSH level, compared to normal rats. The levels and the activities of the studied biomarkers were significantly restored in the animals pre-co-treated with GSE1 or GSE2 (p < 0.05).

3.12. Effect of GSE on the DNA from Cardiac Tissue

The effect of the different treatments on the integrity of genomic DNA from cardiac tissue is illustrated in Figure 4. An intact band was observed in the DNA electrophoretic gel of control rats (lane 1). Significant DNA damage was induced by ISP treatment, resulting in DNA fragmentation showing a mixture of smearing and laddering (lane 4). On the other hand, the pre-co-administration with GSE1 or GSE2 (lanes 5 and 6, respectively) decreased the observed ISP-induced genotoxicity (Figure 4).

3.13. Effect of GSE on Pro-Apoptotic Genes

Figure 5 presents the cardiac mRNA expression of caspase-3, Bax, and Bcl2 in the studied animals. In the ISP group, the results showed a remarkable up-regulation of pro-apoptotic biomarkers caspase-3 and Bax compared to the untreated group. The pre-co-administration with GSE1 or GSE2 significantly reduced the observed overexpression associated with ISP. Alternatively, a down-regulation of the Bcl2 gene was observed for the ISP group, which was especially reverted in the GSE2-treated rats.

3.14. Infarct Size Staining

The myocardial tissue images and infarct size are presented in Figure 6. The control group tissue displayed a normal structure, which was indicated by red color using TTC. Animals that received ISP displayed large necrotic and infarcted areas, identifiable by a pale orange color. It was remarkable that the pre-co-treatment using GSE decreased the infarct size in comparison to MI rats induced by ISP (Figure 6).

3.15. Effect of GSE on the Histology of the Heart Tissue

The histopathologic modification was studied using fixed cardiac slices and H&E staining in all studied groups (Figure 7). The H&E staining of cardiac tissues from the normal group (C) showed several multinucleated myofibers and myocyte necrosis was not observed. The heart tissue of ISP-treated rats showed histopathologic changes as manifested by excessive leukocyte infiltration, myocardial cell necrosis, and separation of cardiac myofibrillar. In contrast with this group, the pre-co-administration with GSE1 reduced the levels of inflammatory cells, and a moderate disturbance of myofibers and little muscle separation was observed (GSE1 + ISP). Moreover, lower myonecrosis and reduced infiltration of inflammatory cells were observed in the GSE2 + ISP group.

4. Discussion

The valorization of grapevine shoots is crucial to promote circularity in the grape and wine sectors. Previous studies have identified stilbenoids in grapevine plant parts of various grapevine cultivars and Vitis species [10,12,24], which are relevant biomolecules to produce bio-based products, including functional ingredients. However, their composition and content are highly variable depending on the cultivar, studied part, and extraction conditions. Therefore, in this work, grapevine shoots from the cultivar ‘Charelo’, which have been poorly studied, were extracted using maceration aided by agitation and ultrasound using the same solvent (80% w/v ethanol) and solid loading. The liquid extracts were analyzed. Preliminarily, it was evidenced that the application of ultrasound required lower energy consumption compared to maceration (0.009 kW h vs. 0.490 kW h, respectively) while increasing the solubilization of the total phenolic content (7.8 mg/g vs 6.5 mg/g of grapevine shoot, respectively). Moreover, ethanol was selected as the extraction agent since it is safer than other organic solvents from the health and environmental points of view to promote sustainable processes [25]. Therefore, the use of UAE with 80% ethanol seems promising for recovering phenolic compounds from grapevine shoots.
The extract obtained by UAE was lyophilized (GSE) and further characterized. The GSE mainly contained stilbenoids, highlighting the presence of trans-resveratrol and trans-ε-viniferin. Trans-resveratrol, in particular, is one of the most interesting food bioactive compounds, being present, for example, in wine and grapes [26], with several reported bioactive properties [13,26,27] and with high commercial potential [9]. The content of this compound in the GSE was increased about 25 times compared to the raw grapevine shoots, i.e., from 1.1 mg/g grapevine shoots to 27.4 mg/g GSE, on a dry basis. This is remarkable since the content of trans-resveratrol in foods (grapes, chocolate, peanuts, etc.) is in the order of μg per g, and in wine, in the order of mg per L; hence, a dose probably too low to present therapeutical relevance in itself [26]. For example, in this work, two dosages of GSE were tested, 20 and 40 mg/kg bw, according to the preliminary toxicity study and a previous study on this animal model [27]. This means that about 0.5 and 1.1 mg/kg bw of trans-resveratrol was administered to the animals. Both GSE treatments reversed the effect of ISP on the animals (see Section 3 for the results, and the discussion below), but the second dose was more effective considering heart gene biomarker expression (Figure 5) and histology analysis (Figure 7). For a 60 kg human, the GSE dose could range from about 0.2 g to 0.4 g of GSE and about 5.5 to 11.0 mg of trans-resveratrol, respectively [15].
Moreover, trans-ε-viniferin (a dimeric form of resveratrol) and other derivatives of trans-resveratrol were found in GSE. These compounds are generated by oxidative polymerization of trans-resveratrol in the plant [28]. The content of stilbenoid oligomers depends on the plant part and cultivar, but the degree of polymerization is increased from the cane (mature and woody shoots) to the rootlets [6]. This agreed with the present results since GSE contained a relatively higher amount of stilbenoids in monomeric and dimeric forms than trimers and tetramers. These compounds can also contribute to the bioactivity of the extract along with other phenolic compounds like flavanols and gallic acid [27], or the trans-resveratrol metabolites generated in vivo after consumption [29].
Various studies have linked the presence of trans-resveratrol in wine to support the French Paradox and the lower incidence of cardiovascular events in that population [27,29]. Moreover, the potential protective role of trans-resveratrol on cardiovascular and heart health has also been evidenced [13]. Hence, in the present work, the possible therapeutic effect of GSE, which contained trans-resveratrol and derivatives (including trans-ε-viniferin), was investigated on cardiac remodeling by MI induction in Wistar rats with ISP. Indeed, MI is the most common source of demise in people suffering from cardiovascular illnesses.
Electrocardiographic abnormalities are the most used criterion for myocardial infarction diagnosis. In the current investigation, the increase in ST-segments observed following ISP treatment was corrected by the pre-co-treatment with GSE. It was clear that the administration of ISP significantly increased the levels of specific diagnostic markers (CK-MB, LDH, AST, and cTn-I), indicating impaired cardiac functions [30]. On the other hand, the pre-co-administration with GSE (20 or 40 mg/kg bw) reduced the amounts of the studied biomarkers. The beneficial effect of GSE was probably due to an improved integrity of the myocardial membrane, thus inhibiting the release of the aforementioned markers into the circulation [31]. The histopathological findings aligned with the biochemical markers, indicating a decrease in the edematous myocardium, without necrosis when animals were treated with GSE.
To further investigate the possible cardioprotective potential of GSE against ISP-induced injury, the serum lipid constituents were measured, namely, TC, TG, LDL-C, and HDL-C. The alteration in the lipid profile markers is considered a main risk factor in MI according to a previous study [32]. It was clear in this study that the pre-co-treatment with GSE nearly restored the elevated levels of plasmatic TC, LDL, and TG of ISP-induced MI in rats. Particularly, the observed cholesterol-lowering properties are probably due to the capacity of the biomolecules in GSE to inhibit key enzymes in cholesterol synthesis, like 3-hidroxi-3-metilglutaril-coenzima A (HMG-CoA) reductase [33]. Moreover, the use of GSE elevated the diminished levels of HDL-C observed in the ISP group, thus promoting cholesterol metabolism in the liver [34]. These findings agree with previous results regarding the capacity of trans-resveratrol to avoid dyslipidemia and myocardial infarction [35].
In addition, Figure 3a shows that the pre-co-administration of GSE with ISP showed an antithrombotic effect by reducing the plasma fibrinogen level. According to a previous study by Mnafgui et al. [36], the detected antithrombotic capacity of GSE might be influenced by the reduction in the protein disulfide isomerase (PDI), a protein involved in blood clotting. As another potential mechanism, a recent study suggests that trans-resveratrol can modulate the tissue factor (TF) (or thromboplastin) activity, concentration, and mRNA expression, while its metabolites can be deconjugated by endothelial cells and then also act by modulating the TF. The TF activates factor VII and triggers thrombosis [37].
The increased MDA levels and protein carbonyls associated with a decreased activity of the antioxidant enzyme system (e.g., SOD and CAT) may cause an increase in free radicals, which are responsible for oxidative stress, which in turn has been associated with MI development [38]. The results shown in Table 5 highlight a rise in the level of MDA when the animals were administered ISP, which was successfully reversed when the rats were treated with GSE. The reduced levels of this marker in GSE pre-co-treated rats could be a result of scavenging capacity against reactive oxygen species (ROS) carried out by natural products [39]. Particularly, trans-resveratrol can act against ROS in multiple ways, including by inhibiting their production and via the upregulation of antioxidant enzyme expression [35].
Furthermore, the groups that received GSE had better levels of CAT, SOD, and GSH, in comparison with the ISP group, suggesting that the acute toxicity induced by ISP was restored. Indeed, decreased levels of GSH, an important reducing agent in the cell, are associated with oxidative stress. These results confirmed one more time the antioxidant potency of GSE. It incited the antioxidant enzymes and restored the GSE level, ameliorating cellular protection against oxidative stress, and overall protecting the myocardium, even at lower dosages compared to other plant species extracts [40,41].
According to Table 5, ISP significantly elevated the plasmatic concentration of Ca2+, which could promote an excessive intracellular Ca2+ level in the cardiomyocytes [42]. The decreased level of the plasmatic Ca2+ following GSE pre-co-treatment seemed to be due to the natural molecules that can block the voltage-dependent L-type Ca2+ channels, according to a previous study [40]. This suggests the favorable impact of GSE on maintaining calcium homeostasis, potentially enhancing cardiac contractile function [43] and therefore avoiding MI [44]. In addition, the present work also evidenced that the pre-co-treatment with GSE improved the ionic homeostasis as confirmed by the increase in the level of Na+. The detected effect could be related to better membrane integrity and the normal function of the sodium–potassium pumps [36], and/or the inhibition of the renin–angiotensin system within the heart [45], in line with the ACE inhibition properties of the GSE.
The effect of ISP on the DNA structure was also targeted. The results of the DNA electrophoresis showed a laddered pattern of DNA fragments in ISP-treated rats in contrast to control animals. The GSE pre-co-treatment was able to decrease the observed changes in the DNA. The cardioprotective effects of GSE could be due to its antioxidative power and therefore the suppression of ROS-induced DNA damage [46].
Furthermore, Figure 3b evidenced the capacity of GSE to inhibit the ACE activity in the plasma of ISP-treated rats. It has been reported that the inhibition of ACE was associated with inhibited expression of the transforming growth factor (TGF)-β1, which is crucial in fibrosis. Hence, it could decrease the fibrotic process [23].

5. Conclusions

This current study offers, for the first time, experimental evidence on the effectiveness of the application of grapevine shoots as a source of biomolecules with cardio-preventive effects against ISP-induced acute MI and cardiac remodeling processes. It was remarkable that GSE enhanced the lipid profile and averted the altered concentration of calcium and sodium in plasma. It also provoked a notable decrease in markers of cardiac dysfunction, DNA fragmentation, and necrosis of the myocardial tissue. Furthermore, this study evidenced the anti-oxidative role of GSE, which increased the antioxidant enzymatic activity and decreased the lipid peroxidation in the heart. Additionally, GSE inhibited ACE activity that could be related to a potential anti-thrombotic effect. The results suggest that the GSE studied could serve to obtain stilbenoids, specifically trans-resveratrol and trans-ε-viniferin, for applications in the food and pharmaceutical industries to improve heart health and antioxidant status.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/foods12234351/s1, Table S1: Primer sequences used for semi-quantitative RT-PCR reactions; Figure S1: Electrocardiogram (ECG) patterns of the control and experimental animals. The control group showed a normal ECG pattern. The isoproterenol (ISP)-treated group showed pathological changes as ST-segment elevation (Pardee wave) (arrow).

Author Contributions

Conceptualization, M.d.M.C. and A.F.; methodology, A.F., I.G.-C., M.d.M.C., N.H., and A.H.H.; software, A.F.; investigation, A.F., I.G.-C., M.d.M.C., N.H., and A.H.H.; resources, I.R., A.F., M.d.M.C., and N.T.; writing—original draft preparation, M.d.M.C. and A.F.; writing—review and editing, M.d.M.C., A.F., I.R., and E.C.; visualization, A.F.; supervision, M.d.M.C., A.F., and N.T.; project administration and funding acquisition, I.R., M.d.M.C., and A.F. All authors have read and agreed to the published version of the manuscript.

Funding

M.d.M.C. expresses her gratitude to the Ministry of Science and Innovation (MCIN) of Spain for the Ramón y Cajal grant (RYC2020-030546-I/AEI/10.13039/501100011033) and the European Social Fund. I.G.-C. appreciates the “Programme of Requalification of the Spanish University System” 2021–2023—Margarita Salas. Support from the grant PID2020-112594RB-C31 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” and “Researchers Supporting Project (RSP2023R17) at King Saud University” is also acknowledged.

Data Availability Statement

The data are contained within the article or Supplementary Materials.

Acknowledgments

The technical and human support provided by CICT of the Universidad de Jaén is gratefully acknowledged. The authors express their appreciation to the Researchers Supporting Project (RSP2023R17) at King Saud University, Riyadh, Saudi Arabia. They would like to express their sincere gratitude to Kais Mnafgui for his assistance in electrocardiogram studies.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. OIV. State of the World Vine and Wine Sector in 2022. Available online: https://www.oiv.int/sites/default/files/documents/2023-04_Press_Conf.pdf (accessed on 1 September 2023).
  2. Pérez-Bermúdez, P.; Olmo, M.; Gil, J.; García-Ferriz, L.; Olmo, C.; Boluda, R.; Gavidia, I. Effects of traditional and light pruning on viticultural and oenological performance of Bobal and Tempranillo vineyards. OENO One 2015, 49, 145–154. [Google Scholar] [CrossRef]
  3. Contreras, M.d.M.; Romero-García, J.M.; López-Linares, J.C.; Romero, I.; Castro, E. Residues from grapevine and wine production as feedstock for a biorefinery. Food Bioprod. Process. 2022, 134, 56–79. [Google Scholar] [CrossRef]
  4. Aliaño-González, M.J.; Richard, T.; Cantos-Villar, E. Grapevine Cane extracts: Raw plant material, extraction methods, quantification, and applications. Biomolecules 2020, 10, 1195. [Google Scholar] [CrossRef] [PubMed]
  5. Delgado-Torre, M.P.; Ferreiro-Vera, C.; Priego-Capote, F.; Pérez-Juan, P.M.; Luque De Castro, M.D. Comparison of accelerated methods for the extraction of phenolic compounds from different vine-shoot cultivars. J. Agric. Food Chem. 2012, 60, 3051–3060. [Google Scholar] [CrossRef]
  6. Goufo, P.; Singh, R.K.; Cortez, I. A reference list of phenolic compounds (including stilbenes) in grapevine (Vitis vinifera L.) roots, woods, canes, stems, and leaves. Antioxidants 2020, 9, 398. [Google Scholar] [CrossRef] [PubMed]
  7. Sánchez-Gómez, R.; Garde-Cerdán, T.; Zalacain, A.; Garcia, R.; Cabrita, M.J.; Salinas, M.R. Vine-shoot waste aqueous extract applied as foliar fertilizer to grapevines: Effect on amino acids and fermentative volatile content. Food Chem. 2016, 197, 132–140. [Google Scholar] [CrossRef] [PubMed]
  8. Dorosh, O.; Moreira, M.M.; Rodrigues, F.; Peixoto, A.F.; Freire, C.; Morais, S.; Delerue-Matos, C. Vine-canes valorisation: Ultrasound-assisted extraction from lab to pilot scale. Molecules 2020, 25, 1739. [Google Scholar] [CrossRef]
  9. Noviello, M.; Caputi, A.F.; Squeo, G.; Paradiso, V.M.; Gambacorta, G.; Caponio, F. Vine shoots as a source of trans-resveratrol and ε-Viniferin: A Study of 23 Italian varieties. Foods 2022, 11, 553. [Google Scholar] [CrossRef]
  10. Loupit, G.; Prigent, S.; Franc, C.; De Revel, G.; Richard, T.; Cookson, S.J.; Fonayet, J.V. Polyphenol profiles of just pruned grapevine canes from wild Vitis Accessions and Vitis vinifera cultivars. J. Agric. Food Chem. 2020, 68, 13397–13407. [Google Scholar] [CrossRef]
  11. Rajha, H.N.; El Kantar, S.; Afif, C.; Boussetta, N.; Louka, N.; Maroun, R.G.; Vorobiev, E. Selective multistage extraction process of biomolecules from vine shoots by a combination of biological, chemical, and physical treatments. Comptes Rendus Chim. 2018, 21, 581–589. [Google Scholar] [CrossRef]
  12. Moreira, M.M.; Barroso, M.F.; Porto, J.V.; Ramalhosa, M.J.; Švarc-Gajić, J.; Estevinho, L.; Morais, S.; Delerue-Matos, C. Potential of Portuguese vine shoot wastes as natural resources of bioactive compounds. Sci. Total Environ. 2018, 634, 831–842. [Google Scholar] [CrossRef]
  13. Raj, P.; Thandapilly, S.J.; Wigle, J.; Zieroth, S.; Netticadan, T. A Comprehensive analysis of the efficacy of resveratrol in atherosclerotic cardiovascular disease, myocardial infarction and heart failure. Molecules 2021, 26, 6600. [Google Scholar] [CrossRef]
  14. Gómez-Cruz, I.; Contreras, M.d.M.; Romero, I.; Ribeiro, B.; Roseiro, L.B.; Duarte, L.C.; Carvalheiro, F.; Castro, E. Strategies for the purification of hydroxytyrosol-rich extracts obtained from exhausted olive pomace. Sep. Purif. Technol. 2023, 325, 124664. [Google Scholar] [CrossRef]
  15. Contreras, M.d.M.; Gómez-Cruz, I.; Feriani, A.; Alwasel, S.; Harrath, A.H.; Romero, I.; Castro, E.; Tlili, N. Hepatopreventive properties of hydroxytyrosol and mannitol-rich extracts obtained from exhausted olive pomace using green extraction methods. Food Funct. 2022, 18, 11915–11928. [Google Scholar] [CrossRef]
  16. Buege, J.A.; Aust, S.D. Microsomal lipid peroxidation. In Methods in Enzymology; Elsevier: Amsterdam, The Netherlands, 1978; pp. 302–310. [Google Scholar]
  17. Aebi, H. Catalase in Vitro. In Methods in Enzymology; Elsevier: Amsterdam, The Netherlands, 1985; pp. 121–126. [Google Scholar]
  18. Marklund, S.; Marklund, G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974, 47, 469–474. [Google Scholar] [CrossRef] [PubMed]
  19. Ellman, G.L. Tissue Sulfhydryl Groups. Arch. Biochem. Biophys. 1959, 82, 70–77. [Google Scholar] [CrossRef] [PubMed]
  20. Chtourou, Y.; Aouey, B.; Kebieche, M.; Fetoui, H. Protective role of naringin against cisplatin induced oxidative stress, inflammatory response and apoptosis in rat striatum via suppressing ROS-mediated NF-ΚB and P53 signaling pathways. Chem. Biol. Interact. 2015, 239, 76–86. [Google Scholar] [CrossRef]
  21. Bradford, M.M. A Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [Google Scholar] [CrossRef]
  22. Feriani, A.; Tir, M.; Gómez-Caravaca, A.M.; Contreras, M.d.M.; Talhaoui, N.; Taamalli, A.; Segura-Carretero, A.; Ghazouani, L.; Mufti, A.; Tlili, N.; et al. HPLC-DAD-ESI-QTOF-MS/MS profiling of Zygophyllum album roots extract and assessment of its cardioprotective effect against deltamethrin-induced myocardial injuries in rat, by suppression of oxidative stress-related inflammation and apoptosis via NF-ΚB signaling pathway. J. Ethnopharmacol. 2020, 247, 112266. [Google Scholar] [CrossRef]
  23. Feriani, A.; Khdhiri, E.; Tir, M.; Elmufti, A.; Tlili, N.; Hajji, R.; Ammar, H.; Allouche, N.; Abid, S.; Ghazouani, L.; et al. (E)-N ′-(1-(7-Hydroxy-2-Oxo-2H-Chromen-3-Yl) Ethylidene) benzohydrazide, a novel synthesized coumarin, ameliorates isoproterenol-induced myocardial infarction in rats through attenuating oxidative stress, inflammation, and apoptosis. Oxid. Med. Cell. Longev. 2020, 2020, 2432918. [Google Scholar] [CrossRef]
  24. Gabaston, J.; Leborgne, C.; Waffo-Teguo, P.; Valls, J.; Palos Pinto, A.; Richard, T.; Cluzet, S.; Mérillon, J.M. Wood and roots of major grapevine cultivars and rootstocks: A comparative analysis of stilbenes by UHPLC-DAD-MS/MS and NMR. Phytochem. Anal. 2019, 30, 320–331. [Google Scholar] [CrossRef] [PubMed]
  25. Attard, T.M.; Bukhanko, N.; Eriksson, D.; Arshadi, M.; Geladi, P.; Bergsten, U.; Budarin, V.L.; Clark, J.H.; Hunt, A.J. Supercritical extraction of waxes and lipids from biomass: A valuable first step towards an integrated biorefinery. J. Clean. Prod. 2018, 177, 684–698. [Google Scholar] [CrossRef]
  26. Weiskirchen, S.; Weiskirchen, R. Resveratrol: How much wine do you have to drink to stay healthy? Adv. Nutr. 2016, 7, 706–718. [Google Scholar] [CrossRef] [PubMed]
  27. Salehi, B.; Vlaisavljevic, S.; Adetunji, C.O.; Adetunji, J.B.; Kregiel, D.; Antolak, H.; Pawlikowska, E.; Uprety, Y.; Mileski, K.S.; Devkota, H.P.; et al. Plants of the genus Vitis: Phenolic compounds, anticancer properties and clinical relevance. Trends Food Sci. Technol. 2019, 91, 362–379. [Google Scholar] [CrossRef]
  28. Rayne, S.; Karacabey, E.; Mazza, G. Grape Cane Waste as a Source of trans-resveratrol and trans-viniferin: High-value phytochemicals with medicinal and anti-phytopathogenic applications. Ind. Crops Prod. 2008, 27, 335–340. [Google Scholar] [CrossRef]
  29. Jarosova, V.; Vesely, O.; Doskocil, I.; Tomisova, K.; Marsik, P.; Jaimes, J.D.; Smejkal, K.; Kloucek, P.; Havlik, J. Metabolism of cis-and trans-resveratrol and dihydroresveratrol in an intestinal epithelial model. Nutrients 2020, 12, 595. [Google Scholar] [CrossRef]
  30. Aboubakr, M.; Elsayd, F.; Soliman, A.; Fadl, S.E.; El-Shafey, A.; Abdelhiee, E.Y. L-Carnitine and vitamin E ameliorate cardiotoxicity induced by tilmicosin in rats. Environ. Sci. Pollut. Res. 2020, 27, 23026–23034. [Google Scholar] [CrossRef]
  31. Feriani, A.; Tir, M.; Aldahmash, W.; Mnafgui, K.; Hichem, A.; Gómez-Caravaca, A.M.; Contreras, M.d.M.; Taamalli, A.; Alwasel, S.; Segura-Carretero, A.; et al. In vivo evaluation and molecular docking studies of Schinus molle L. fruit extract protective effect against isoproterenol-induced infarction in rats. Environ. Sci. Pollut. Res. 2022, 29, 80910–80925. [Google Scholar] [CrossRef]
  32. Vijayakumar, R.; Nachiappan, V. Cassia Auriculata Flower Extract Attenuates Hyperlipidemia in Male Wistar Rats by Regulating the Hepatic Cholesterol Metabolism. Biomed. Pharmacother. 2017, 95, 394–401. [Google Scholar] [CrossRef]
  33. Venkadeswaran, K.; Thomas, P.A.; Geraldine, P. An experimental evaluation of the anti-atherogenic potential of the plant, piper betle, and its active constitutent, eugenol, in rats fed an atherogenic diet. Biomed. Pharmacother. 2016, 80, 276–288. [Google Scholar] [CrossRef]
  34. Roy, S.J.; Mainzen Prince, P.S. Protective Effects of Sinapic Acid on Cardiac Hypertrophy, Dyslipidaemia and Altered Electrocardiogram in Isoproterenol-Induced Myocardial Infarcted Rats. Eur. J. Pharmacol. 2013, 699, 213–218. [Google Scholar] [CrossRef]
  35. Fan, S.; Hu, Y.; You, Y.; Xue, W.; Chai, R.; Zhang, X.; Shou, X.; Shi, J. Role of resveratrol in inhibiting pathological cardiac remodeling. Front. Pharmacol. 2022, 13, 3452. [Google Scholar] [CrossRef] [PubMed]
  36. Mnafgui, K.; Khdhiri, E.; Hajji, R.; Feriani, A.; Ivan da Silva, F.; Laíres da Silva Santos, A.; Tlili, A.; Mlayeh, S.; Bouzidi, M.; Ammar, H.; et al. Potential effect of new (E)-4-hydroxy-N’-(1-(7-hydroxy-2-oxo-2H-chromen-3-Yl) ethylidene) benzohydrazide against acute myocardial infarction: Haemodynamic, biochemical and histological studies. Clin. Exp. Pharmacol. Physiol. 2021, 48, 107–120. [Google Scholar] [CrossRef]
  37. Fernández-Castillejo, S.; Macià, A.; Motilva, M.J.; Catalán, Ú.; Solà, R. Endothelial cells deconjugate resveratrol metabolites to free resveratrol: A possible role in tissue factor modulation. Mol. Nutr. Food Res. 2019, 63, 1800715. [Google Scholar] [CrossRef] [PubMed]
  38. Ardjmand, A.; Shahaboddin, M.E.; Mazoochi, T.; Heydari, A.; Ghavipanjeh, G. Cardioprotective effects of cerebrolysin on the lesion severity and inflammatory factors in a rat model of isoproterenol-induced myocardial injury. Pharmacol. Rep. 2019, 71, 682–687. [Google Scholar] [CrossRef] [PubMed]
  39. Feriani, A.; Contreras, M.d.M.; Talhaoui, N.; Gómez-Caravaca, A.M.; Taamalli, A.; Segura-Carretero, A.; Ghazouani, L.; El Feki, A.; Allagui, M.S. Protective effect of Globularia alypum leaves against deltamethrin-induced nephrotoxicity in rats and determination of its bioactive compounds using high-performance liquid chromatography coupled with electrospray ionization tandem quadrupole–time-of-flight. J. Funct. Foods 2017, 32, 139–148. [Google Scholar] [CrossRef]
  40. Paulino, E.T.; Barros Ferreira, A.K.; da Silva, J.C.G.; Ferreira Costa, C.D.; Smaniotto, S.; de Araújo-Júnior, J.X.; Silva Júnior, E.F.; Bortoluzzi, J.H.; Nogueira Ribeiro, Ê.A. Cardioprotective effects induced by hydroalcoholic extract of leaves of Alpinia zerumbet on myocardial infarction in rats. J. Ethnopharmacol. 2019, 242, 112037. [Google Scholar] [CrossRef]
  41. Eladwy, R.A.; Mantawy, E.M.; El-Bakly, W.M.; Fares, M.; Ramadan, L.A.; Azab, S.S. Mechanistic insights to the cardioprotective effect of blueberry nutraceutical extract in isoprenaline-induced cardiac hypertrophy. Phytomedicine 2018, 51, 84–93. [Google Scholar] [CrossRef]
  42. Kronenbitter, A.; Funk, F.; Hackert, K.; Gorreßen, S.; Glaser, D.; Boknik, P.; Poschmann, G.; Stühler, K.; Isić, M.; Krüger, M.; et al. Impaired Ca2+ cycling of nonischemic myocytes contributes to sarcomere dysfunction early after myocardial infarction. J. Mol. Cell. Cardiol. 2018, 119, 28–39. [Google Scholar] [CrossRef]
  43. Yang, S.; Chou, G.; Li, Q. Cardioprotective role of azafrin in against myocardial injury in rats via activation of the Nrf2-ARE Pathway. Phytomedicine 2018, 47, 12–22. [Google Scholar] [CrossRef]
  44. Han, X.; Li, M.; Zhao, Z.; Zhang, Y.; Zhang, J.; Zhang, X.; Zhang, Y.; Guan, S.; Chu, L. mechanisms underlying the cardio-protection of total ginsenosides against myocardial ischemia in rats in vivo and in vitro: Possible involvement of L-type Ca 2+ channels, contractility and Ca 2+ homeostasis. J. Pharmacol. Sci. 2019, 139, 240–248. [Google Scholar] [CrossRef] [PubMed]
  45. Kang, N.N.; Fu, L.; Xu, J.; Han, Y.; Cao, J.X.; Sun, J.F.; Zheng, M. Testosterone improves cardiac function and alters angiotensin ii receptors in isoproterenol-induced heart failure. Arch. Cardiovasc. Dis. 2012, 105, 68–76. [Google Scholar] [CrossRef] [PubMed]
  46. Aybastıer, Ö.; Dawbaa, S.; Demir, C. Investigation of antioxidant ability of grape seeds extract to prevent oxidatively induced DNA damage by gas chromatography-tandem mass spectrometry. J. Chromatogr. B 2018, 1072, 328–335. [Google Scholar] [CrossRef] [PubMed]
Foods 12 04351 g001
Figure 1. (a) UV chromatogram of the vine shoot extract at 280 nm. (b) Distribution of phenolic classes and (c) stilbenoids using the relative area obtained by RP-QTOF-MS. Simple phenols refer to gallic acid and phenol aldehydes.
Figure 1. (a) UV chromatogram of the vine shoot extract at 280 nm. (b) Distribution of phenolic classes and (c) stilbenoids using the relative area obtained by RP-QTOF-MS. Simple phenols refer to gallic acid and phenol aldehydes.
Foods 12 04351 g001
Foods 12 04351 g002
Figure 2. Plasma activities of (a) creatine kinase-MB (CK-MB), (b) lactate dehydrogenase (LDH), (c) aspartate aminotransferase (AST), and (d) cTn-I levels in normal and treated rats (mean ± SD; n = 6 rats per group). C, control; GSE, grapevine shoot extract; ISP, isoproterenol. **** p < 0.0001: ISP vs. C; *** p < 0.001 or **** p < 0.0001: GSE1 + ISP/GSE2 + ISP vs. ISP; ns (not significant): GSE1 + ISP vs. GSE2 + ISP.
Figure 2. Plasma activities of (a) creatine kinase-MB (CK-MB), (b) lactate dehydrogenase (LDH), (c) aspartate aminotransferase (AST), and (d) cTn-I levels in normal and treated rats (mean ± SD; n = 6 rats per group). C, control; GSE, grapevine shoot extract; ISP, isoproterenol. **** p < 0.0001: ISP vs. C; *** p < 0.001 or **** p < 0.0001: GSE1 + ISP/GSE2 + ISP vs. ISP; ns (not significant): GSE1 + ISP vs. GSE2 + ISP.
Foods 12 04351 g002
Foods 12 04351 g003
Figure 3. Changes in the (a) fibrinogen levels and (b) angiotensin-converting enzyme (ACE) activity in the plasma of different animal groups (mean ± SD; n= 6 rats per group). C, control; GSE, grapevine shoot extract; ISP, isoproterenol. **** p < 0.0001: ISP vs. C; ** p < 0.01 or **** p < 0.0001: GSE1 + ISP/GSE2 + ISP vs. ISP.
Figure 3. Changes in the (a) fibrinogen levels and (b) angiotensin-converting enzyme (ACE) activity in the plasma of different animal groups (mean ± SD; n= 6 rats per group). C, control; GSE, grapevine shoot extract; ISP, isoproterenol. **** p < 0.0001: ISP vs. C; ** p < 0.01 or **** p < 0.0001: GSE1 + ISP/GSE2 + ISP vs. ISP.
Foods 12 04351 g003
Foods 12 04351 g004
Figure 4. DNA electrophoresis on agarose gel after extraction from the heart tissue of the control group (C) (lane 1) and animals treated with grapevine shoot extract (GSE), GSE1 (lane 2) and GSE2 (lane 3), isoproterenol (ISP) (lane 4), and with GSE and ISP, GSE1 + ISP (lane 5), and GSE2 + ISP (lane 6).
Figure 4. DNA electrophoresis on agarose gel after extraction from the heart tissue of the control group (C) (lane 1) and animals treated with grapevine shoot extract (GSE), GSE1 (lane 2) and GSE2 (lane 3), isoproterenol (ISP) (lane 4), and with GSE and ISP, GSE1 + ISP (lane 5), and GSE2 + ISP (lane 6).
Foods 12 04351 g004
Foods 12 04351 g005
Figure 5. Agarose gel electrophoresis of caspase 3, Bax, and Bcl2 genes in the heart tissue of the control group (C) (lane 1) and animals treated with grapevine shoot extract (GSE): GSE1 (lane 2) and GSE2 (lane 3), isoproterenol (ISP) (lane 4), and with GSE and ISP, GSE1 + ISP (lane 5), and GSE2 + ISP (lane 6).
Figure 5. Agarose gel electrophoresis of caspase 3, Bax, and Bcl2 genes in the heart tissue of the control group (C) (lane 1) and animals treated with grapevine shoot extract (GSE): GSE1 (lane 2) and GSE2 (lane 3), isoproterenol (ISP) (lane 4), and with GSE and ISP, GSE1 + ISP (lane 5), and GSE2 + ISP (lane 6).
Foods 12 04351 g005
Foods 12 04351 g006
Figure 6. Myocardial tissue from the studied animal groups after TTC staining and photomicrography. C, control; GSE, grapevine shoot extract; ISP, isoproterenol. Arrow: infarcted areas.
Figure 6. Myocardial tissue from the studied animal groups after TTC staining and photomicrography. C, control; GSE, grapevine shoot extract; ISP, isoproterenol. Arrow: infarcted areas.
Foods 12 04351 g006
Foods 12 04351 g007
Figure 7. Histological images of heart tissue of the control and treated groups using hematoxylin and eosin staining at ×200 magnification. C, control; GSE, grapevine shoot extract; ISP, isoproterenol. Arrow: inflammatory cell infiltration; asterix: separation of cardiac myofibrillar; N: myocardial cell necrosis.
Figure 7. Histological images of heart tissue of the control and treated groups using hematoxylin and eosin staining at ×200 magnification. C, control; GSE, grapevine shoot extract; ISP, isoproterenol. Arrow: inflammatory cell infiltration; asterix: separation of cardiac myofibrillar; N: myocardial cell necrosis.
Foods 12 04351 g007
Table 1. Contents of phenolic compounds (TPC), trans-resveratrol, trans-ε-viniferin, and the antioxidant activity of the grapevine shoot extract (GSE).
Table 1. Contents of phenolic compounds (TPC), trans-resveratrol, trans-ε-viniferin, and the antioxidant activity of the grapevine shoot extract (GSE).
ComponentContent
TPC (mg gallic acid eq./g GSE)207.3 ± 3.5
Trans-resveratrol (mg/g GSE)27.4 ± 0.3
Trans-ε-viniferin (mg/g GSE)29.2 ± 0.2
FRAP (mg Trolox eq./g GSE)137.58 ± 3.57
Table 2. Phenolic compounds extracted from grapevine shoots and characterized based on RP-HPLC-QTOF-MS analysis.
Table 2. Phenolic compounds extracted from grapevine shoots and characterized based on RP-HPLC-QTOF-MS analysis.
Proposed CompoundRT (min)[M-H]-
m/z		Molecular FormulaScoreError
(ppm)		Phenolic Class
Gallic acid0.8169.014C7H6O598.9−1.0Hydroxybenzoic acid
Dihydroxybenzaldehyde2.1137.025C7H6O399.2−0.7Phenol aldehyde
Hydroxybenzaldehyde3.4121.030C7H6O299.7−0.7Phenol aldehyde
(Epi)catechin B-type dimer4.4577.135C30H26O1291.6−1.3Flavanol dimer
Catechin4.4289.073C15H14O694.7−3.0Flavanol monomer
Epicatechin6.5289.072C15H14O697.0−2.0Flavanol monomer
Oxidized resveratrol dimer 17.6471.145C28H24O798.40.5Stilbenoid dimer
Oxidized resveratrol dimer 27.9471.146C28H24O796.3−2.0Stilbenoid dimer
Resveratrol hexoside9.3389.125C20H22O896.0−1.9Stilbenoid monomer
Oxidized resveratrol dimer 39.4471.145C28H24O795.8−1.2Stilbenoid dimer
(Epi)catechin gallate9.6441.084C22H18O1097.7−1.8Flavanol monomer
Piceatannol9.9243.067C14H12O496.7−1.4Stilbenoid monomer
Ampelopsin A10.5469.129C28H22O797.5−0.4Stilbenoid dimer
trans-Resveratrol12.3227.072C14H12O396.6−2.0Stilbenoid monomer
Pallidol12.7453.135C28H22O697.1−1.8Stilbenoid dimer
Resveratrol isomer14.0227.072C14H12O398.2−0.7Stilbenoid monomer
Viniferol E15.5923.270C56H44O1397.81.3Stilbenoid tetramer
Hopeaphenol16.1905.260C56H42O1298.70.6Stilbenoid tetramer
Viniferin isomer 116.6453.135C28H22O696.3−1.3Stilbenoid dimer
Hopeaphenol isomer16.6905.260C56H42O1294.00.0Stilbenoid tetramer
Vitisinol C17.2427.155C27H24O598.3−0.4Stilbenoid dimer
trans-ε-Viniferin17.6453.135C28H22O696.6−0.2Stilbenoid dimer
Miyabenol C18.8679.198C42H32O997.0−0.6Stilbenoid trimer
Viniferin isomer 218.9453.135C28H22O698.4−1.4Stilbenoid dimer
α-Viniferin19.9677.183C42H30O990.0−2.0Stilbenoid trimer
Vitisin B isomer 123.2905.259C56H42O1296.51.9Stilbenoid tetramer
Vitisin B isomer 223.4905.259C56H42O1298.31.3Stilbenoid tetramer
Table 3. Other components of the grapevine shoot extract (GSE).
Table 3. Other components of the grapevine shoot extract (GSE).
ComponentContent
Ultimate analysis (%, g/100 g GSE)
Carbon52.87 ± 0.11
Hydrogen6.69 ± 0.01
Nitrogen1.06 ± 0.03
Sulfur0.07 ± 0.09
Other components (%, g/100 g GSE)
Moisture9.24 ± 0.11
Ash6.33 ± 0.08
Other components (mg/g GSE)
Protein 266.3 ± 1.9
Oligomeric glucose59.8 ± 4.4
Oligomeric galactose3.1 ± 0.3
Monomeric glucose55.7 ± 5.3
Monomeric galactose5.0 ± 1.0
Mannitol27.8 ± 2.3
Organic acids 138.9 ± 0.5
1 As acetic and formic acids. 2 Determined as nitrogen × 6.25.
Table 4. Rats’ body and heart weight, and cardiac weight index (CWI) of the control (C) and treated groups (mean ± SD, n = 6 rats per group).
Table 4. Rats’ body and heart weight, and cardiac weight index (CWI) of the control (C) and treated groups (mean ± SD, n = 6 rats per group).
ParameterCGSE1GSE2ISPGSE1 + ISPGSE2 + ISP
Body weight (g)285.5 ± 2291.8 ± 2.9289.9 ± 0.9282.7 ± 4.2291.4 ± 2.1286.4 ± 4.2
Heart weight (g)0.73 ± 0.100.86 ± 0.050.80 ± 0.121.74 ± 0.10 ****1.07 ± 0.11 ***0.89 ± 0.10 ***
CWI 0.25 ± 0.020.29 ± 0.030.27 ± 0.030.61 ± 0.06 ****0.36 ± 0.07 ***0.31 ± 0.01 ***
GSE, grapevine shoot extract; ISP, isoproterenol. CWI: heart weight × 100/body weight. **** p < 0.0001: ISP vs. C; *** p < 0.001: GSE1 + ISP/GSE2 + ISP vs. ISP.
Table 5. Variation in the concentrations of lipids and studied electrolytes in plasma and thiobarbituric acid reactive substances (TBARS), enzymatic antioxidants, and total cellular glutathione (GSH) in the cardiac tissue of different experimental groups (mean ± SD, n = 6 rats per group).
Table 5. Variation in the concentrations of lipids and studied electrolytes in plasma and thiobarbituric acid reactive substances (TBARS), enzymatic antioxidants, and total cellular glutathione (GSH) in the cardiac tissue of different experimental groups (mean ± SD, n = 6 rats per group).
ParameterCGSE1GSE2ISPGSE1 + ISPGSE2 + ISP
Plasma lipids
TC (mg/dL)67.6 ± 2.070.4 ± 3.670.8 ± 7.8142.0 ± 6.5****82.4 ± 9.9 ****85.7 ± 4.0 ****
TG (mg/dL)32.8 ± 3.630.5 ± 4.935.1 ± 4.675.4 ± 4.9 ****46.3 ± 10.8 ****40.4 ± 4.0 ****
LDL-C (mg/dL)23.9 ± 2.528.8 ± 5.825.1 ± 7.098.9 ± 10.9 ****52.2 ± 14.3 ****40.0 ± 8.5 ****
HDL-C (mg/dL)36.5 ± 6.132.4 ± 4.4230.3 ± 2.817.8 ± 3.2 ****29.0 ± 5.7 ***30.5 ± 4.7 ***
Plasma electrolytes
Na+ (mmol/L)133.8 ± 2.3130.2 ± 4.4119.7 ± 19.790.97 ± 4.6 ****117.1 ± 8.2 **122.1 ± 12.7 ***
Ca2+ (mmol/L)6.9 ± 1.06.9 ± 2.46.348 ± 4.114.4 ± 0.8 ****8.7 ± 2.2 **8.3 ± 1.5 ***
TBARS and antioxidant status
TBARS (nmol MDA/g tissue)0.79 ± 0.381.19 ± 0.761.27 ± 0.416.62 ± 0.71 ****2.10 ± 1.02 ****1.97 ± 0.93 ****
CAT (µmol destroyed H2O2/min per mg protein)21.77 ± 3.3821.28 ± 4.7219.23 ± 4.957.11 ± 3.71 ****15.65 ± 3.33 **18.58 ± 2.41 ***
SOD (U/mg protein)26.53 ± 3.1424.07 ± 4.4727.03 ± 4.8911.85 ± 3.45 ****20.90 ± 4.98 **21.62 ± 4.09 **
GSH (U/mg protein)6.32 ± 1.096.028 ± 0.436.34 ± 0.652.15 ± 0.55 ****5.33 ± 0.61 ****5.38 ± 1.01 ****
CAT, catalase; HDL-C, HDL-cholesterol; LDL-C, LDL-cholesterol; MDA, malondialdehyde; SOD, superoxide dismutase; TC, total cholesterol; TG, triglycerides. C, control; GSE, grapevine shoot extract; ISP, isoproterenol. **** p < 0.0001: ISP vs. C; ** p < 0.01, *** p < 0.001 or **** p < 0.0001: GSE1 + ISP/GSE2 + ISP vs. ISP.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Contreras, M.d.M.; Feriani, A.; Gómez-Cruz, I.; Hfaiedh, N.; Harrath, A.H.; Romero, I.; Castro, E.; Tlili, N. Grapevine Shoot Extract Rich in Trans-Resveratrol and Trans-ε-Viniferin: Evaluation of Their Potential Use for Cardiac Health. Foods 2023, 12, 4351. https://doi.org/10.3390/foods12234351

AMA Style

Contreras MdM, Feriani A, Gómez-Cruz I, Hfaiedh N, Harrath AH, Romero I, Castro E, Tlili N. Grapevine Shoot Extract Rich in Trans-Resveratrol and Trans-ε-Viniferin: Evaluation of Their Potential Use for Cardiac Health. Foods. 2023; 12(23):4351. https://doi.org/10.3390/foods12234351

Chicago/Turabian Style

Contreras, María del Mar, Anouar Feriani, Irene Gómez-Cruz, Najla Hfaiedh, Abdel Halim Harrath, Inmaculada Romero, Eulogio Castro, and Nizar Tlili. 2023. "Grapevine Shoot Extract Rich in Trans-Resveratrol and Trans-ε-Viniferin: Evaluation of Their Potential Use for Cardiac Health" Foods 12, no. 23: 4351. https://doi.org/10.3390/foods12234351

APA Style

Contreras, M. d. M., Feriani, A., Gómez-Cruz, I., Hfaiedh, N., Harrath, A. H., Romero, I., Castro, E., & Tlili, N. (2023). Grapevine Shoot Extract Rich in Trans-Resveratrol and Trans-ε-Viniferin: Evaluation of Their Potential Use for Cardiac Health. Foods, 12(23), 4351. https://doi.org/10.3390/foods12234351

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop